Exposure to secondhand smoke remains a significant yet preventable cause of respiratory illness worldwide. Individuals who do not smoke but are regularly around smokers inhale thousands of harmful chemicals, including carcinogens and irritants that affect airway and lung function. Infants and children are particularly vulnerable, with increased risks of asthma development, recurrent respiratory infections, and impaired lung growth. Adults exposed chronically face higher incidences of chronic obstructive pulmonary disease and cardiovascular complications, showing how passive exposure can be just as dangerous as direct smoking. Public spaces, homes, and workplaces continue to be environments where involuntary inhalation compromises long-term respiratory well-being.
Reducing the health burden of passive smoking requires a combination of public policy, healthcare intervention, and community awareness. Smoke-free laws in restaurants, offices, and public transport have demonstrated measurable reductions in hospitalizations for respiratory conditions, underscoring the role of legislation in protecting vulnerable groups. Healthcare providers also play a role by counseling patients about risks, identifying early symptoms linked to passive exposure, and advocating preventive strategies. The broader consequences of secondhand smoke health impacts extend into family and societal health, making education and enforcement programs critical. Integrating awareness campaigns with policy measures gradually reduces exposure and promotes healthier communities, breaking the cycle of involuntary smoke-related harm.
Title : Novel signaling mechanisms and innovative therapeutic strategies of pulmonary hypertension
Yong Xiao Wang, Albany Medical College, United States
Title : Changing population immunity to COVID-19 in the context of infection, vaccination and emerging SARS-CoV-2 variants
Ranjan Ramasamy, ID-FISH Technology, United States
Title : Susceptibility to SARS-CoV-2 infection and nasal air conditioning ability
Ranjan Ramasamy, ID-FISH Technology, United States
Title : Comparative evaluation of DECAF and BAP 65 scores in predicting outcomes of COPD exacerbations among in patients at Vicente Sotto Memorial Medical Center
Allanys Joy Q Pino, Vicente Sotto Memorial Medical Center, Philippines
Title :
Saurabh Chattopadhyay, University of Kentucky College of Medicine, United States
Title : Personalized and precision Medicine (PPM) as a unique healthcare model through biodesign driven and inspired biotech, translational applications and pulmonology related marketing to secure the human healthcare, wellness and biosafety
Sergey Suchkov, N.D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences & InMedStar, Russian Federation